Lam Research (LRCX)
(Delayed Data from NSDQ)
$847.37 USD
+11.65 (1.39%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $847.37 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$847.37 USD
+11.65 (1.39%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $847.37 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Zacks News
Lam Research Corporation (LRCX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Lam Research (LRCX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Semiconductor ETFs Shining Amid Mixed Numbers in Q4 Earnings
by Sweta Killa
Mixed quarterly results from well-known players slowed down the rally in the sector lately.
The Zacks Analyst Blog Highlights Abbott Laboratories, Boeing, Diageo, Lam Research and Freeport-McMoRan
by Zacks Equity Research
Abbott Laboratories, Boeing, Diageo, Lam Research and Freeport-McMoRan are included in this Analyst Blog.
Top Analyst Reports for Abbott Laboratories, Boeing & Diageo
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), The Boeing Company (BA) and Diageo plc (DEO).
Stock Market News for Feb 1, 2023
by Zacks Equity Research
U.S. stock markets closed sharply higher on Tuesday.
Lam Research Corporation (LRCX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Lam Research (LRCX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Not the Best Time for the Semi Equipment Industry
by Sejuti Banerjea
While stocks like ASML and LRCX are good long-term bets on the Semiconductor Equipment - Wafer Fabrication industry, only ASML is likely to see continued growth this year.
Lam Research (LRCX) Q2 Earnings & Revenues Beat, Rise Y/Y
by Zacks Equity Research
Lam Research's (LRCX) fiscal second quarter results reflect strength across systems and the customer support business.
Mercury Systems (MRCY) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Along with increasing modernization in radar, electronic warfare and C4I, Mercury Systems' (MRCY) Q2 performance is likely to have been driven by revenue contributions from the newly acquired businesses.
Lam Research (LRCX) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Lam Research (LRCX) delivered earnings and revenue surprises of 7.64% and 3.87%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Stocks Stage Rally Despite Growing Recession Indicators
by Mayur Thaker
All eyes on Q4 '22 earnings over the next two weeks.
Factors Setting the Tone for Celestica (CLS) in Q4 Earnings
by Zacks Equity Research
Celestica's (CLS) Q4 earnings are likely to have benefited from strength in the ATS segment and the HPS business despite soft demand from OEM customers.
Jack Henry (JKHY) to Reduce Carbon Footprint With New Targets
by Zacks Equity Research
Jack Henry (JKHY) gears up to set science-based climate targets to achieve the long-term sustainability of its business model.
Will Supply-Chain Woes Dampen Roper's (ROP) Q4 Earnings?
by Zacks Equity Research
Supply-chain and cost woes are likely to have hurt Roper's (ROP) Q4 earnings, partly offset by strength across the Deltek, Vertafore and Aderant businesses within the Application Software unit.
Lam Research (LRCX) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Lam Research's (LRCX) second-quarter fiscal 2023 results are likely to gain from strong demand for semiconductor equipment. However, supply-chain constraints might have been a headwind.
Factors Likely to Decide CACI's Fate This Earnings Season
by Zacks Equity Research
CACI's Q2 results are likely to benefit from disciplined business development actions, consistent operational excellence and high customer satisfaction.
Investors Heavily Search Lam Research Corporation (LRCX): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Lam Research (LRCX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
F5 (FFIV) Gears Up for Q1 Earnings: What's in the Offing?
by Zacks Equity Research
F5's (FFIV) Q1 performance is likely to have benefited from the hybrid work environment and the ongoing digital transformation wave, which is boosting the demand for secured communication networks.
What's in the Offing for Logitech (LOGI) in Q3 Earnings?
by Zacks Equity Research
The declining demand for PCs is likely to have hurt Logitech's (LOGI) peripheral sales in the third quarter of fiscal 2023.
Lam Research (LRCX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Lam Research (LRCX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lam Research (LRCX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed the most recent trading day at $470.99, moving -0.57% from the previous trading session.
The Zacks Analyst Blog Highlights UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy
by Zacks Equity Research
UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy are part of the Zacks top analyst blog.
Top Research Reports for UnitedHealth Group, Coca-Cola & Roche Holding
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), The Coca-Cola Company (KO) and Roche Holding AG (RHHBY).
Progress Software (PRGS) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Progress Software's (PRGS) fourth-quarter fiscal 2022 results are likely to reflect gains from a strong portfolio that comprises Chef, OpenEdge, DataDirect and Sitefinity solutions.
Lam Research (LRCX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed the most recent trading day at $464.30, moving +1.24% from the previous trading session.